Related Experiment Video
Updated: Feb 27, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma
Matteo Marchesini1, Yamini Ogoti1, Elena Fiorini1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
Amplification of 1q21 occurs in approximately 30% of de novo and 70% of relapsed multiple myeloma (MM) and is correlated with disease progression and drug resistance. Here, we provide evidence that the 1q21 amplification-driven overexpression of ILF2 in MM promotes tolerance of genomic instability and drives resistance to DNA-damaging agents. Mechanistically, elevated ILF2 expression exerts resistance to genotoxic agents by modulating YB-1 nuclear localization and interaction with the splicing factor U2AF65, which promotes mRNA processing and the stabilization of transcripts involved in homologous recombination in response to DNA damage. The intimate link between 1q21-amplified ILF2 and the regulation of RNA splicing of DNA repair genes may be exploited to optimize the use of DNA-damaging agents in patients with high-risk MM.
Insights
Amplification of 1q21 in multiple myeloma (MM) elevates ILF2, promoting genomic instability and resistance to DNA-damaging agents. Targeting this pathway could improve treatments for high-risk MM patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- 1q21 amplification is common in multiple myeloma (MM), linked to progression and drug resistance.
- Overexpression of ILF2 is a consequence of 1q21 amplification in MM.
Purpose of the Study:
- To investigate the role of ILF2 in mediating resistance to DNA-damaging agents in MM.
- To elucidate the molecular mechanisms by which ILF2 confers drug resistance.
Main Methods:
- Analysis of 1q21 amplification and ILF2 expression in MM patient samples.
- Investigating the effect of ILF2 on genomic instability and DNA repair pathways.
- Studying the interaction of ILF2 with YB-1 and U2AF65 in response to genotoxic stress.
Main Results:
- 1q21 amplification drives ILF2 overexpression in MM.
- Elevated ILF2 promotes tolerance to genomic instability and resistance to DNA-damaging agents.
- ILF2 modulates YB-1 nuclear localization and U2AF65 interaction, enhancing mRNA processing and homologous recombination repair.
Conclusions:
- ILF2 overexpression, driven by 1q21 amplification, is a key mechanism of drug resistance in MM.
- The ILF2-mediated regulation of RNA splicing in DNA repair genes offers a potential therapeutic target.
- Targeting this pathway may optimize DNA-damaging agent efficacy in high-risk MM.
More Related Videos
Related Concept Videos
RNA Splicing
Abnormal Proliferation
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of the Unfolded Protein Response

